Aspire Biopharma Holdings Inc. Ordinary Shares - Class A ASBP 深 沪
等待开盘 09-17 09:30:00 美东时间
0.4453
+0.033
+8.11%
华盛通- 最 高0.4663
- 今 开0.427
- 成交量 158.67万股
- 最 低 0.4125
- 昨 收 0.4119
- 总市值 2205.39万
- 52周最高 15.80
- 市盈率 静 --
- 换手率 3.20%
- 52周最低 0.215
- 委 比 -69.70%
- 总股本 4952.60万
- 历史最高 15.80
- 量 比 1.56
- 振 幅 13.06%
- 历史最低 0.215
- 每 手 1
- 风险率
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Aspire Biopharma Expands BUZZ BOMB Pre-Workout Production With New SupraNaturals Manufacturing Agreement To Meet Growing Market Demand
Part of New Contract Manufacturing Agreement with SupraNaturals to Secure Additional Production CapacitySupraNaturals is a leading private label manufacturer in the health and wellness industryBUZZ BOMB™
09-16 20:37
Aspire Biopharma Announces Final Results From Crossover Bioavailability Trial To Assess Safety, Tolerability, PK And PD Of Aspire's Investigational New Sublingual Aspirin Product Compared To Chewed Uncoated Aspirin Tablets In Healthy Adults
Aspire's sublingual aspirin formulation significantly inhibited serum thromboxane B2 (TxB2) within the first two minutes after dosingTxB2 is a biomarker indicating aspirin's effect on platelet aggregation, the clumping
09-03 20:32
Aspire Biopharma Secures $9.7M Through Securities Agreement
Aspire Biopharma Holdings ( ($ASBP) ) just unveiled an update. On August 19, 20...
08-23 05:53
Aspire Shares Are Trading Higher Monday: What's Going On?
Aspire shares are trading higher Monday after the company announced top-line data from its crossover bioavailability trial.
08-19 03:18
Aspire Biopharma Hldgs Q2 EPS $(0.04)
Aspire Biopharma Hldgs (NASDAQ:ASBP) reported quarterly losses of $(0.04) per share.
08-14 05:50
Aspire Biopharma Launches BUZZ BOMB Pre-Workout With Innovative Sublingual Delivery
BUZZ BOMB™ is bringing its unique delivery technology benefits to the multi-billion-dollar pre-workout to help athletes and fitness enthusiasts maximize their performance potential30,000 BUZZ BOMB™ sample
08-13 21:13
Aspire Biopharma names new executive chair
Aspire Biopharma (NASDAQ:ASBP) said that Board of Directors has appointed Kraig Higginson as interim CEO, effective July 24, 2025. Mr. Higginson serves as Chairman of the Board and previously served a...
07-31 12:49
Aspire Biopharma Announces Leadership Reshuffle Amid Resignations
Aspire Biopharma Holdings ( ($ASBP) ) just unveiled an update. On July 24, 2025...
07-31 05:49
Aspire Biopharma Plans To Launch Newsublingual Pre-Workout Supplement, BUZZ BOMB, At FitCon And FitExpo
Sublingual nano technology delivers 50mg of caffeine rapidly to the body, bringing its unique benefits to the pre-workout marketESTERO, FL / ACCESS Newswire / July 22, 2025 / Aspire Biopharma Holdings, Inc. (NASDAQ:ASBP)
07-22 22:49
